Sign inJoin waitlistJoin the waitlist

Carlton Schwab

Physician · Spartanburg Medical Center

Credentials: · · · · · ·

History

Spartanburg Medical Center
Present

Obstetrics and Gynecology
Medical University of South Carolina College of Medicine
2016–2020
Gynecologic Oncology
Yale School of Medicine
2013–2016
Louisiana State University Shreveport, Centenary College of Louisiana
Med Univ of South Carolina Coll of Med
2005–2009
The University of the South (2002
1998–2002

Research

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Proceedings of the National Academy of Sciences of the United States of America · 2016 · 189 citations
Immunotherapy and targeted therapy for cervical cancer: an update
Review · Expert Review of Anticancer Therapy · 2016 · 91 citations
Ethanol suppresses cytokine responses induced through Toll-like receptors as well as innate resistance to Escherichia coli in a mouse model for binge drinking
Alcohol · 2004 · Last of 5 authors · 73 citations

Alessandro Santin
28 papers
Jonathan Black
21 papers · 21 as a fellow
PS
Peter Schwartz
19 papers
Masoud Azodi
18 papers
DE
Diana English
17 papers · 17 as a fellow
Dan-Arin Silasi
16 papers
Elena Ratner
16 papers · 10 as a resident
GM
Gulden Menderes
11 papers · 10 as a fellow
Thomas Rutherford
9 papers
Babak Litkouhi
5 papers
Dana Roque
5 papers · 5 as a fellow
Natalia Buza
5 papers

Clinical trials

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Site PI · Recruiting
NRG Oncology
2020–2047
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Site PI · Unknown · Phase 3
Gynecologic Oncology Group
2012